Boenisch Sandra 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Jan 8, 2020
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-06+70,000→ 70,000 totalExercise: $2.96Exp: 2030-01-06→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The options shall vest upon the achievement of a certain clinical trial milestone with respect to the Issuer's Phase 2 clinical trial program of Anavex(R)2-73 for the treatment of Rett syndrome.